BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lovastatin
,
rs2300478
,
SIRT1
,
Apoptosis
,
Lung cancer
,
Prostate
,
Anticancer prodrugs
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CYP51
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Testes
Colon mucosa
Ileum mucosa
Fetal liver
Testis seminiferous tubule
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
High fat diet
Eating / feeding / drinking finding
Microbial culture finding
Weight finding
Placental insufficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Niacinamide
Hexachlorophene
vinylidene chloride
4-octylphenol
geraniol
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Stat3
ZW10
DBI
CYP7A1
MDM2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Inhibitory effect of magnetic iron-oxide nanoparticles on the pattern of expression of lanosterol 14…
Strategies of targeting CYP51 for IFIs therapy: Emerging prospects, opportunities and challenges.
Characterization of Prototheca CYP51/ERG11 as a possible target for therapeutic drugs.
Male germ cell-specific knockout of cholesterogenic cytochrome P450 lanosterol 14α-demethylase (Cyp5…
Synthesis of obtusifoliol and analogues as CYP51 substrates.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Inter…
A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the To…
A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Acute Vaginal Candidias…
A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Ye…
Fungal Infections in Patients With Hematological Malignancies
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ